ZBH Stock Recent News
ZBH LATEST HEADLINES
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Keri Mattox - Chief Communications and Administration Officer Ivan Tornos - President and CEO Suky Upadhyay - Executive Vice President, Finance, Operations and Supply Chain, and CFO Conference Call Participants Travis Steed - Bank of America Steve Lichtman - Oppenheimer & Company Vik Chopra - Wells Fargo Rick Wise - Stifel Imron Zafar - Deutsche Bank Caitlin Cronin - Canaccord Genuity Mike Matson - Needham & Company Robbie Marcus - JPMorgan Chris Pasquale - Nephron Shagun Singh - RBC Operator Good morning, ladies and gentlemen. And welcome to the Zimmer Biomet First Quarter 2024 Earnings Conference Call.
Each of Zimmer Biomet's (ZBH) geographic segments records strong year-over-year sales growth on a reported basis, as well as at CER.
While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.94 per share, beating the Zacks Consensus Estimate of $1.87 per share. This compares to earnings of $1.89 per share a year ago.
Medtech firm Zimmer Biomet Holdings beat Wall Street estimates for first-quarter profit on Thursday, on the back of robust demand for its devices that are used in knee and hip reconstruction procedures.
Besides Wall Street's top -and-bottom-line estimates for Zimmer (ZBH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Zimmer (ZBH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Within the Hips business, Zimmer Biomet (ZBH) is expected to have witnessed procedure volume recovery, banking on strategic product launches in the first quarter.